FDA approves ketamine-derived depression drug

7:24pm PST - March 5th, 2019    ketamine - The Verge

The US Food and Drug Administration has approved a new depression drug, esketamine, for patients who have not responded to other antidepressants. The treatment, a nasal spray related to the party drug ketamine, will be the first fast-acting depression drug on…